Reference
Wong AS, et al. Pushing the limits of immune-related response: a case of "extreme pseudoprogression". Cancer Immunology Immunotherapy 67: 1105-1111, No. 7, Jul 2018. Available from: URL: https://doi.org/10.1007/s00262-018-2167-3 -Singapore
Rights and permissions
About this article
Cite this article
Nivolumab. Reactions Weekly 1714, 296 (2018). https://doi.org/10.1007/s40278-018-50476-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-50476-x